What is Chardan Capital’s Forecast for iBio FY2025 Earnings?
iBio, Inc. (NYSE:IBIO – Free Report) – Investment analysts at Chardan Capital reduced their FY2025 earnings estimates for iBio in a note issued to investors on Monday, May 5th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings of ($1.71) per share for the year, down from their prior forecast of […]
